An economic downturn always has effects that reverberate across an industry, and perhaps one of the most visible reverberations is in the realm of personnel - more layoffs and less hiring a
Graham Belgrave is Senior Vice President, Head of Global Medical and Regulatory Affairs and Managing Director Europe at Advanced Clinical. He has over 39 years of experience successf
Advanced Clinical is proud to be a privately-held, single-owner company, which was founded in 1994 and has grown organically—not by merger or acquisition—into an award-winning culture, trus
Not only did the COVID-19 pandemic bring lockdown rules and increased safety protocols, it also led to delays, reconfigurations, limited patient access, and other restrictions for life scie
The US FDA announced today that it has cleared two novel gene therapies for sickle cell disease: Vertex Pharmaceuticals' Casgevy and bluebird bio's Lyfgenia.
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio